Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
Arienti F, Gambacorti-Passerini C, Borin L, Rivoltini L, Orazi A, Pogliani EM, Corneo G, Parmiani G. Arienti F, et al. Among authors: pogliani em. Ann Oncol. 1992 Feb;3(2):155-62. doi: 10.1093/oxfordjournals.annonc.a058133. Ann Oncol. 1992. PMID: 1606087 Free article.
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571.
Gambacorti-Passerini C, Barni R, le Coutre P, Zucchetti M, Cabrita G, Cleris L, Rossi F, Gianazza E, Brueggen J, Cozens R, Pioltelli P, Pogliani E, Corneo G, Formelli F, D'Incalci M. Gambacorti-Passerini C, et al. Among authors: pogliani e. J Natl Cancer Inst. 2000 Oct 18;92(20):1641-50. doi: 10.1093/jnci/92.20.1641. J Natl Cancer Inst. 2000. PMID: 11036109 Free article.
Antifibrinolytic therapy in acute promyelocytic leukemia.
Pogliani EM, Salvatore M, Masera G, Corneo G. Pogliani EM, et al. Acta Haematol. 1989;81(1):58-9. doi: 10.1159/000205403. Acta Haematol. 1989. PMID: 2494837 Free article. No abstract available.
Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl+ cells obtained from leukemic patients.
Gambacorti-Passerini CB, Rossi F, Verga M, Ruchatz H, Gunby R, Frapolli R, Zucchetti M, Scapozza L, Bungaro S, Tornaghi L, Rossi F, Pioltelli P, Pogliani E, D'Incalci M, Corneo G. Gambacorti-Passerini CB, et al. Among authors: pogliani e. Blood Cells Mol Dis. 2002 May-Jun;28(3):361-72. doi: 10.1006/bcmd.2002.0526. Blood Cells Mol Dis. 2002. PMID: 12367580 Clinical Trial.
293 results